Abeona Therapeutics Inc. · Brief

Next report

11 days

Nov 11 · before openest.Q3 FY26

Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory

0 of 8≥ implied

avg implied: ±28.9%
avg realized: ±7.4%

Nov 14 '24±12.6%▼−2.46%×0.20

Mar 20 '25±43.6%▼−1.15%×0.03

May 15 '25±8.3%▲+7.42%×0.89

Aug 14 '25±28.8%▲+10.21%×0.35

Q3 FY25±41.4%▲+18.47%×0.45

Q1 FY26±44.6%▼−3.84%×0.09

May 13 '26±21.9%▲+0.53%×0.02

Q2 FY26±29.7%▼−14.95%×0.50

quarterimplied−45%0+45%realized×

Q2 FY26±29.7%▼−14.95%×0.50

May '26±21.9%▲+0.53%×0.02

Q1 FY26±44.6%▼−3.84%×0.09

Q3 FY25±41.4%▲+18.47%×0.45

Aug '25±28.8%▲+10.21%×0.35

May '25±8.3%▲+7.42%×0.89

2 older reports

Mar '25±43.6%▼−1.15%×0.03

Nov '24±12.6%▼−2.46%×0.20

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2 of 3

126managers reporting a position in the latest quarterly filings13F · Jun 30 '26

22managers whose positions together make up four fifths of reported value13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options implied rangeEarnings history

7 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ABEO report session

Customers 1

TSHATaysha Gene Therapies×0.62

× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 29impliedImplied move: ±20.5% into Nov 11 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.